الصفحة الرئيسية>>Signaling Pathways>> Antibody-drug Conjugate/ADC Related>> ADC Linker>>Propargyl-PEG4-thiol

Propargyl-PEG4-thiol

رقم الكتالوجGC67451

Propargyl-PEG4-thiol هو رابط PROTAC قائم على PEG يمكن استخدامه في تخليق PROTACs. Propargyl-PEG4-thiol هو رابط ADC غير قابل للكسر يستخدم في تخليق اتحادات الأجسام المضادة والأدوية (ADCs).

Products are for research use only. Not for human use. We do not sell to patients.

Propargyl-PEG4-thiol التركيب الكيميائي

Cas No.: 1347750-80-4

الحجم السعر المخزون الكميّة
250mg
1131٫00
متوفر
500mg
1657٫00
متوفر
1g
2376٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Propargyl-PEG4-thiol is a PEG-based PROTAC linker can be used in the synthesis of PROTACs. Propargyl-PEG4-thiol is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1].

PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.

[1]. Goswami LN, et al. Efficient synthesis of diverse heterobifunctionalized clickable oligo(ethylene glycol) linkers: potential applications in bioconjugation and targeted drug delivery.

مراجعات

Review for Propargyl-PEG4-thiol

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Propargyl-PEG4-thiol

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.